Skip to main content
. 2013 Mar 10;163(3):326–334. doi: 10.1016/j.ijcard.2011.08.849

Fig. 3.

Fig. 3

IL-17 mediated upregulation of Cxcl1 and IL-6 in cardiac myocytes is MAPK dependent. (A) NRVMs were treated with 10 ng/ml IL-17 for the indicated times and cell lysates were analysed by Western blot using the indicated antibodies. (B) NRVMs were pre-treated for 30 min with the indicated inhibitors followed by IL-17 stimulation for 6 h. The expression of Cxcl1 and IL-6 was measured by qPCR. Statistical analysis was carried out using a student's t-test. *p < 0.05, **p < 0.01, **p < 0.001.